ofloxacin and cardiovascular agents

ofloxacin has been researched along with cardiovascular agents in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bardini, J; Caliendo, G; Cohen, H; el-Chaar, GM; Frank, C; Profeta, LM; Schwenk, MH; Talbot, KA	1
Al-Khadimi, Z; Chow, WA; Doroshow, JH; Frankel, P; Lawrence, J; Leong, L; Lim, D; Longmate, J; Margolin, K; Morgan, RJ; Raschko, J; Shibata, S; Somlo, G; Synold, TW; Tetef, ML; Twardowski, P; Yen, Y	1

Reviews

1 review(s) available for ofloxacin and cardiovascular agents

Article	Year
New drugs on the horizon. Clinics in podiatric medicine and surgery, 1992, Volume: 9, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Aminosalicylic Acids; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiemetics; Antineoplastic Agents; Antiviral Agents; Cardiovascular Agents; Dose-Response Relationship, Drug; Drug Interactions; Foscarnet; Hematinics; Humans; Imidazoles; Ofloxacin; Ondansetron; Pharmaceutical Preparations; Phosphonoacetic Acid; Serotonin Antagonists	1992

Article

Year

New drugs on the horizon.

Clinics in podiatric medicine and surgery, 1992, Volume: 9, Issue:2

Topics: Acquired Immunodeficiency Syndrome; Aminosalicylic Acids; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiemetics; Antineoplastic Agents; Antiviral Agents; Cardiovascular Agents; Dose-Response Relationship, Drug; Drug Interactions; Foscarnet; Hematinics; Humans; Imidazoles; Ofloxacin; Ondansetron; Pharmaceutical Preparations; Phosphonoacetic Acid; Serotonin Antagonists

1992

Trials

1 trial(s) available for ofloxacin and cardiovascular agents

Article	Year
Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies. Cancer chemotherapy and pharmacology, 2004, Volume: 54, Issue:3 Topics: Adult; Antibiotics, Antineoplastic; Cardiovascular Agents; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Heart Failure; Humans; Infusions, Intravenous; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Razoxane; Sarcoma; Sepsis; Treatment Outcome	2004

Article

Year

Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies.

Cancer chemotherapy and pharmacology, 2004, Volume: 54, Issue:3

Topics: Adult; Antibiotics, Antineoplastic; Cardiovascular Agents; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Heart Failure; Humans; Infusions, Intravenous; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Razoxane; Sarcoma; Sepsis; Treatment Outcome

2004